These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2257351)
1. Old BCG replaced by new vaccine? Human leukocyte antigens (HLA) and mycobacterial disease. de Vries R Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):30-1. PubMed ID: 2257351 [No Abstract] [Full Text] [Related]
2. The immunological and epidemiological significance of environmental mycobacteria on leprosy and tuberculosis control. Pallen MJ Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):231-45. PubMed ID: 6427125 [No Abstract] [Full Text] [Related]
3. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis. Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701 [TBL] [Abstract][Full Text] [Related]
5. Towards a vaccine against leprosy. Sengupta U Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444 [No Abstract] [Full Text] [Related]
6. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy. Gormus BJ; Meyers WM Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362 [TBL] [Abstract][Full Text] [Related]
7. The cellular and molecular basis of immunity against mycobacterial diseases. Colston MJ Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118 [No Abstract] [Full Text] [Related]
8. The immunology of leprosy; unravelling an enigma. Choudhuri K Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):430-47. PubMed ID: 7594927 [No Abstract] [Full Text] [Related]
9. Mycobacterium vaccae and immune responses: implications for leprosy control. Swinburne S; Brown IN; Brown CA Lepr Rev; 1985 Sep; 56(3):209-20. PubMed ID: 4058233 [No Abstract] [Full Text] [Related]
10. Prospects for new interventions in the treatment and prevention of mycobacterial disease. Young DB; Duncan K Annu Rev Microbiol; 1995; 49():641-73. PubMed ID: 8561475 [TBL] [Abstract][Full Text] [Related]
11. Strategy for leprosy control. Lagrange PH; Stach JL Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):278-88. PubMed ID: 4020217 [No Abstract] [Full Text] [Related]
16. [Report on the effect of vaccination with BCG in the protection against mycobacterium infections]. Rojas-Espinosa O Rev Latinoam Microbiol; 1976; 18(1):7-10. PubMed ID: 1070775 [No Abstract] [Full Text] [Related]
18. Efficacy of leprosy vaccine. Fine PE; Smith PG Nature; 1992 Dec; 360(6403):406. PubMed ID: 1448161 [No Abstract] [Full Text] [Related]
19. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ; Kingston AE; Colston MJ Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217 [TBL] [Abstract][Full Text] [Related]
20. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy. Zodpey SP Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]